Caliway Biopharmaceuticals Co Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2 TWD
−351.92 M TWD
38.04 M TWD
1.26 B
About Caliway Biopharmaceuticals Co Ltd
Sector
Industry
CEO
Vivian Ling
Website
Headquarters
New Taipei City
Founded
2012
IPO date
Oct 2, 2024
Identifiers
2
ISIN TW0006919004
Caliway Biopharmaceuticals Co. Ltd. offers pharmaceutical services. It focuses on medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics to help patients suffering from illness or life threatening diseases. The company was founded in 2012 and is headquartered in New Taipei City, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of 6919 is 88.2 TWD — it has decreased by −3.18% in the past 24 hours. Watch Caliway Biopharmaceuticals Co Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange Caliway Biopharmaceuticals Co Ltd stocks are traded under the ticker 6919.
6919 stock has fallen by −9.05% compared to the previous week, the month change is a −14.59% fall, over the last year Caliway Biopharmaceuticals Co Ltd has showed a −9.91% decrease.
6919 reached its all-time high on Sep 8, 2025 with the price of 277.0 TWD, and its all-time low was 43.6 TWD and was reached on Oct 16, 2024. View more price dynamics on 6919 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6919 stock is 2.76% volatile and has beta coefficient of 0.41. Track Caliway Biopharmaceuticals Co Ltd stock price on the chart and check out the list of the most volatile stocks — is Caliway Biopharmaceuticals Co Ltd there?
Today Caliway Biopharmaceuticals Co Ltd has the market capitalization of 142.10 B, it has increased by 1.49% over the last week.
Yes, you can track Caliway Biopharmaceuticals Co Ltd financials in yearly and quarterly reports right on TradingView.
Caliway Biopharmaceuticals Co Ltd is going to release the next earnings report on Aug 7, 2026. Keep track of upcoming events with our Earnings Calendar.
6919 net income for the last quarter is −107.75 M TWD, while the quarter before that showed 80.19 M TWD of net income which accounts for 0.00% change. Track more Caliway Biopharmaceuticals Co Ltd financial stats to get the full picture.
No, 6919 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Caliway Biopharmaceuticals Co Ltd EBITDA is −694.41 M TWD, and current EBITDA margin is −1.78 K%. See more stats in Caliway Biopharmaceuticals Co Ltd financial statements.
Like other stocks, 6919 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Caliway Biopharmaceuticals Co Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Caliway Biopharmaceuticals Co Ltd technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Caliway Biopharmaceuticals Co Ltd stock shows the sell signal. See more of Caliway Biopharmaceuticals Co Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.